Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Journal of Clinical Epidemiology|June 17, 2020
Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)Alejandro Ruiz-Patiño, Andrés Felipe Cardona, Oscar Arrieta, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, et al.
Journal of the National Cancer Institute|September 1, 2021
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic ImplicationsRoberto Moretto, Andrew Elliott, Jian Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Clinical and Immunological Implications of Frameshift Mutations in Lung CancerYoung Kwang Chae, Pedro Viveiros, Gilberto Lopes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Safety and Tolerability of Lete-cel in NSCLC-ReplyMehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung CancerMehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
JCO Precision Oncology|February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Future Oncology (London, England)|January 10, 2024
BIPOC experiences of (anti-)racist patient engagement in adolescent and young adult oncology research: an electronic Delphi studyChristabel K Cheung, Kimberly A Miller, Trenette Clark Goings, et al.
The Lancet. Diabetes & Endocrinology|June 12, 2021
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 studyVivek Subbiah, Mimi I Hu, Lori J Wirth, et al.
JCO Oncology Practice|October 7, 2024
Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of PracticeNazli Dizman, Ziad Bakouny, Tarek Haykal, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Journal of Clinical Epidemiology|June 17, 2020
Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)Alejandro Ruiz-Patiño, Andrés Felipe Cardona, Oscar Arrieta, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, et al.
Journal of the National Cancer Institute|September 1, 2021
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic ImplicationsRoberto Moretto, Andrew Elliott, Jian Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Clinical and Immunological Implications of Frameshift Mutations in Lung CancerYoung Kwang Chae, Pedro Viveiros, Gilberto Lopes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Safety and Tolerability of Lete-cel in NSCLC-ReplyMehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung CancerMehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
JCO Precision Oncology|February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Future Oncology (London, England)|January 10, 2024
BIPOC experiences of (anti-)racist patient engagement in adolescent and young adult oncology research: an electronic Delphi studyChristabel K Cheung, Kimberly A Miller, Trenette Clark Goings, et al.
The Lancet. Diabetes & Endocrinology|June 12, 2021
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 studyVivek Subbiah, Mimi I Hu, Lori J Wirth, et al.
JCO Oncology Practice|October 7, 2024
Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of PracticeNazli Dizman, Ziad Bakouny, Tarek Haykal, et al.
Pageof 18